Epidemiological Analysis and Effective Control of COVID-19 Outbreaks Caused by the Omicron Subvariant BA.2 in a Medium-sized City in China, 2022

被引:0
作者
Yang, Zhu [1 ,2 ]
Zhao, Jinhong [3 ]
Zhong, Shuzhi [4 ]
Wu, Yikun [4 ]
Ye, Bingjie [5 ]
Wang, Yiming [5 ]
Xiao, Minmin [1 ,2 ]
机构
[1] Wannan Med Coll, Dept Med Microbiol & Immunol, Wuhu 241002, Peoples R China
[2] Second Peoples Hosp Wuhu City, Clin Lab, Wuhu 241001, Peoples R China
[3] Wannan Med Coll, Dept Parasitol, Wuhu, Peoples R China
[4] Wannan Med Coll, Dept Histol & Embryol, Wuhu, Peoples R China
[5] Wannan Med Coll, Dept Clin Med, Wuhu, Peoples R China
关键词
COVID-19; Omicron Subvariant BA; 2; Epidemiology; China;
D O I
10.5812/jjm-136649
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: More and more variants of concern (VOCs) of SARS-CoV-2 continued to emerge in different regions worldwide. Objectives: Studies on COVID-19 outbreaks caused by different VOCs are critical for understanding their infections in humans in different regions.Methods: In this descriptive study, the individual information of 64 confirmed COVID-19 cases reported between March 3 and April 26, 2022, was collected, and the epidemiological features were analyzed.Results: We found COVID-19 epidemic caused by Omicron subvariant BA.2 in 2022 had unique characteristics compared to the earliest COVID-19 outbreaks in 2020 in Wuhu city. First, the geographic distribution of COVID-19 cases was highly concentrated, and most infections (58/64, 90.62%) were identified in one district in this study. Second, the mean age of COVID-19 cases in this study was 39.57 & PLUSMN; 16.39 years old, which was younger than the COVID-19 cases identified in Wuhan and Wuhu cities in 2020. Third, the spanned period of the COVID-19 outbreak in this study was shorter than the COVID-19 outbreak in 2020 in Wuhu city (13 days vs. 34 days).Conclusions: This study illustrates the epidemic of COVID-19 in Wuhu city from March to April 2022, and our result provides valuable information about COVID-19 outbreak caused by omicron subvariant BA.2. It also provides insights into developing effective strategies, such as high coverage of COVID-19 vaccination, lockdown policies, Ankang code, and population-bases COVID-19 screening, for successfully controlling the potential outbreaks caused by Omicron or future novel variants of SARS-CoV-2 in the medium-sized city like Wuhu.
引用
收藏
页数:7
相关论文
共 20 条
[1]  
Anhui, 2022, PRESS C COVID 19 EP
[2]  
[Anonymous], 2021, WEEKLY EPIDEMIOLOGIC, V46th
[3]   Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines [J].
Araf, Yusha ;
Akter, Fariya ;
Tang, Yan-dong ;
Fatemi, Rabeya ;
Parvez, Md Sorwer Alam ;
Zheng, Chunfu ;
Hossain, Md Golzar .
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) :1825-1832
[4]   Novel SARS-CoV-2 variants: the pandemics within the pandemic [J].
Boehm, Erik ;
Kronig, Ilona ;
Neher, Richard A. ;
Eckerle, Isabella ;
Vetter, Pauline ;
Kaiser, Laurent .
CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) :1109-1117
[5]   SARS-CoV-2 variant biology: immune escape, transmission and fitness [J].
Carabelli, Alessandro G. ;
Peacock, Thomas P. ;
Thorne, Lucy G. ;
Harvey, William T. ;
Hughes, Joseph ;
Peacock, Sharon J. ;
Barclay, Wendy S. ;
de Silva, Thushan, I ;
Towers, Greg J. ;
Robertson, David L. .
NATURE REVIEWS MICROBIOLOGY, 2023, 21 (03) :162-177
[6]   Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: A descriptive study [J].
Chen, Zhiyuan ;
Deng, Xiaowei ;
Fang, Liqun ;
Sun, Kaiyuan ;
Wu, Yanpeng ;
Che, Tianle ;
Zou, Junyi ;
Cai, Jun ;
Liu, Hengcong ;
Wang, Yan ;
Wang, Tao ;
Tian, Yuyang ;
Zheng, Nan ;
Yan, Xuemei ;
Sun, Ruijia ;
Xu, Xiangyanyu ;
Zhou, Xiaoyu ;
Ge, Shijia ;
Liang, Yuxia ;
Yi, Lan ;
Yang, Juan ;
Zhang, Juanjuan ;
Ajelli, Marco ;
Yu, Hongjie .
LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2022, 29
[7]   Public Health Measures and the Control of COVID-19 in China [J].
Cheng, Zhangkai Jason ;
Zhan, Zhiqing ;
Xue, Mingshan ;
Zheng, Peiyan ;
Lyu, Jiali ;
Ma, Jing ;
Zhang, Xiaohua Douglas ;
Luo, Wenting ;
Huang, Huimin ;
Zhang, Yong ;
Wang, Hongman ;
Zhong, Nanshan ;
Sun, Baoqing .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 64 (01) :1-16
[8]   Viral targets for vaccines against COVID-19 [J].
Dai, Lianpan ;
Gao, George F. .
NATURE REVIEWS IMMUNOLOGY, 2021, 21 (02) :73-82
[9]  
Doosti-Irani A, 2022, IRAN J PUBLIC HEALTH, V51, P886, DOI 10.18502/ijph.v51i4.9250
[10]  
Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI [10.3760/cma.j.issn.0254-6450.2020.02.003, 10.46234/ccdcw2020.032]